SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
about
SIRT2 as a Therapeutic Target for Age-Related DisordersGTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylationSir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signalingSynthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitorsTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesProtective effects and mechanisms of sirtuins in the nervous systemGrowing the growth cone: remodeling the cytoskeleton to promote axon regenerationSIRT1 and SIRT2: emerging targets in neurodegenerationSirtuins in hematological aging and malignancyFrom sirtuin biology to human diseases: an updateGroup IVA Cytosolic Phospholipase A2 Regulates the G2-to-M Transition by Modulating the Activity of Tumor Suppressor SIRT2.The promise and perils of HDAC inhibitors in neurodegenerationThe Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNSThe sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemiaSIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivoPitfalls in the detection of cholesterol in Huntington's disease modelsCholesterol Modifies Huntingtin Binding to, Disruption of, and Aggregation on Lipid Membranes.Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitorsFunctional genetic variants within the SIRT2 gene promoter in acute myocardial infarction.Sirtuin-2 Protects Neural Cells from Oxidative Stress and Is Elevated in Neurodegeneration.Drosophila Sirt2/mammalian SIRT3 deacetylates ATP synthase β and regulates complex V activity.Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP.Epigenetic regulation of cholesterol homeostasis.Network organization of the huntingtin proteomic interactome in mammalian brain.SIRT2 plays a key role in both cell cycle regulation and cell survival of BV2 microglia.Therapeutic approaches to preventing cell death in Huntington diseaseSilencing of SIRT2 induces cell death and a decrease in the intracellular ATP level of PC12 cells.Inhibition of Sirtuin 2 exerts neuroprotection in aging rats with increased neonatal iron intakeSirtuin 1 activator SRT2104 protects Huntington's disease mice.Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspectiveAn exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease.Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.The human sirtuin family: evolutionary divergences and functions.Design and Evaluation of 3-(Benzylthio)benzamide Derivatives as Potent and Selective SIRT2 InhibitorsAging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7Insight into the Mechanism of Intramolecular Inhibition of the Catalytic Activity of Sirtuin 2 (SIRT2).Drosophila models of proteinopathies: the little fly that could.Suppression of protein aggregation by chaperone modification of high molecular weight complexes3-(N-arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2)
P2860
Q21129286-107CF3DF-69F6-4C9A-90B6-D5D7EEA8071DQ21144926-1C9A64AF-A871-467E-A4E4-FC30519402C2Q24293305-CBD402F2-E5D2-4B48-9DEE-F07C4F2B9FE1Q24338727-E15F9D34-A679-4C9B-8A8B-3EFA918D146AQ24613541-E51006AA-6E1A-42D3-B249-4C9CA67061BCQ26771812-7869D84B-A9CB-430B-8BC7-4B07461B8CDCQ26825585-C6FC11FF-4FB2-4B86-9A30-E42D21B5BB6DQ26829489-4D2570CD-5F26-4F6E-90EC-B1A4FA33DABDQ26864929-5F6D8BC2-50D8-40DD-A694-48AE61866A7DQ26991467-A70C7B2D-E1F8-4A4C-A2FC-40794322BE11Q27022606-0C67B781-A740-4521-A2C2-02BE94F948BBQ27320850-9D1CF79A-2EA1-4A90-BDF6-6E24842A79C4Q28087539-933E2168-8FE4-4AB0-BDFC-4041ECD0B2CCQ28244138-C1983C31-AABA-4D39-AEDD-D1DC947937F9Q28255782-67E2C209-8CD2-4A9B-9F53-95D0261B1048Q28482270-0A57D65D-F761-473D-A17D-5F99643085CBQ28484973-ADA4532C-7EDB-4686-8CBF-A32CD81C0DCCQ30787791-3E5EF269-9EA3-4FF4-A5DD-27C73F1CCA17Q33603921-042CC8A9-28EA-4A09-AFED-99A089C84A11Q33605950-1A6597C7-E5D6-4FBE-8261-33059C37D2D8Q33786835-825B5580-F94B-4094-8F0F-19AF808C8BE2Q33937684-61B16E0E-D72E-48F3-B22F-B28DE6FAEE5DQ33953637-5D9755A8-AE4B-4493-B96C-2F5ACB8C1313Q34238886-053D4D50-7391-4BAB-AA56-0E1CAA60BB21Q34287971-E5ABD53A-CD7F-4D7D-894F-22928DF9E0DEQ34400393-D5762A86-88BA-48DB-B2A8-6633BCB405F8Q34411338-1A97F3FE-BDE7-4009-9F51-BA50AA37B873Q34747946-9D87E075-EAD0-46E5-88CD-A9FD891C7365Q34798799-A453A2B7-C601-41B5-93C6-63288FC22F0CQ34824858-0E92B5C8-21BF-4B70-B572-EF5EF489D028Q35024695-91BEEB45-D199-45A7-86FD-2DAAF317185AQ35135962-EC5F843B-9EAD-4C19-9133-F9430BEA447FQ35154482-A66AEA05-934A-4438-A930-CEA5DBBE887FQ35592289-B677954B-0A23-4C82-9197-C0F9B0D6E142Q35615138-58ED8248-BFA9-4B2E-94EC-60762F2E470DQ35740789-7A2F3DCB-57EE-4647-972F-4F8EB80B1AC1Q35788698-8A788E92-D272-4BC0-9824-2BDFFE31CA6CQ35791494-6F745AA4-D9C7-4624-96EE-2E1A329DFB33Q35888633-C5DCE271-8193-45B5-8E2D-801107907CC7Q35889785-B107A4B3-817D-4E30-A0B9-E50271AA3B74
P2860
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
@ast
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
@en
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
@nl
type
label
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
@ast
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
@en
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
@nl
prefLabel
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
@ast
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
@en
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
@nl
P2093
P2860
P50
P3181
P356
P1476
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
@en
P2093
Aleksey G Kazantsev
Alex Parker
Alexandre Kuhn
Allison Amore
David M Taylor
Donna L Smith
Emmanuel Lambert
Heike Runne
Hilary Moffitt
J Lawrence Marsh
P2860
P304
P3181
P356
10.1073/PNAS.1002924107
P407
P577
2010-04-27T00:00:00Z